Increasing studies have shown that ANLN is highly expressed in multiple cancers, including breast cancer, ovarian cancer, kidney cancer, colorectal cancer, hepatocellular carcinoma, lung cancer, and pancreatic tumors [9–14]. Here, ANLN is linked to breast carcinoma.